Eli Lilly, Canada Spar Over $383M NAFTA Arbitration Claim
Eli Lilly is improperly asking arbitrators to weigh whether the Canadian judiciary wrongly terminated its drug patents, Canada argued in documents released Wednesday that call for the U.S. drugmaker's CA$500 million...To view the full article, register now.
Already a subscriber? Click here to view full article